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Purpose: Developmental abnormalities of the ocular anterior segment in some cases can lead to ocular
hypertension and glaucoma. CPAMD8 is a gene of unknown function recently associated with ocular anterior
segment dysgenesis, myopia, and ectopia lentis. We sought to assess the contribution of biallelic CPAMD8
variants to childhood and juvenile open-angle glaucoma.
Design: Retrospective, multicenter case series.
Participants: A total of 268 probands and their relatives with a diagnosis of childhood or juvenile open-angle
glaucoma.
Purpose: Developmental abnormalities of the ocular anterior segment in some cases can lead to ocular
hypertension and glaucoma. CPAMD8 is a gene of unknown function recently associated with ocular anterior
segment dysgenesis, myopia, and ectopia lentis. We sought to assess the contribution of biallelic CPAMD8
variants to childhood and juvenile open-angle glaucoma.
Methods: Patients underwent a comprehensive ophthalmic assessment, with DNA from patients and their
relatives subjected to genome, exome, or capillary sequencing. CPAMD8 RNA expression analysis was per-
formed on tissues dissected from cadaveric human eyes.
Main Outcome Measures: Diagnostic yield within a cohort of childhood and juvenile open-angle glaucoma,
prevalence and risk of ophthalmic phenotypes, and relative expression of CPAMD8 in the human eye.
Results: We identified rare (allele frequency < 4105) biallelic CPAMD8 variants in 5.7% (5/88) of probands
with childhood glaucoma and 2.1% (2/96) of probands with juvenile open-angle glaucoma. When including family
members, we identified 11 individuals with biallelic variants in CPAMD8 from 7 unrelated families. Nine of these
individuals were diagnosed with glaucoma (9/11, 81.8%), with a mean age at diagnosis of 9.2214.89 years, and
all individuals with glaucoma required 1 or more incisional procedures to control high intraocular pressure. Iris
abnormalities were observed in 9 of 11 individuals, cataract was observed in 8 of 11 individuals (72.7%), and
retinal detachment was observed in 3 of 11 individuals (27.3%). CPAMD8 expression was highest in neural
crestederived tissues of the adult anterior segment, suggesting that CPAMD8 variation may cause malformation
or obstruction of key drainage structures.
Conclusions: Biallelic CPAMD8 variation was associated with a highly heterogeneous phenotype and in our
cohorts was the second most common inherited cause of childhood glaucoma after CYP1B1 and juvenile open-
angle glaucoma after MYOC. CPAMD8 sequencing should be considered in the investigation of both childhood
and juvenile open-angle glaucoma, particularly when associated with iris abnormalities, cataract, or retinal
detachment. Ophthalmology 2020;-:1e9 ª 2020 by the American Academy of Ophthalmology. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Supplemental material available at www.aaojournal.org.Anterior segment dysgenesis (ASD) is a heterogeneous
group of ocular developmental disorders affecting the iris,
cornea, lens, or aqueous humor outflow structures and is
frequently associated with secondary glaucoma. Associatedª 2020 by the American Academy of Ophthalmology
This is an open access article under the CC BY-NC-ND license (http://creativeco
mmons.org/licenses/by-nc-nd/4.0/). Published by Elsevier Inc.defects include hypoplasia of the iris stroma, corectopia,
pseudopolycoria, posterior embryotoxon, abnormal irido-
corneal angle, iridocorneal adhesions, corneal opacity,
and corneal vascularization. The most common ASD1https://doi.org/10.1016/j.ophtha.2019.12.024
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“Axenfeld-Rieger syndrome” (ARS), when associated with
systemic features. Individuals with ARS have a 50% to 60%
lifetime risk of developing glaucoma, which can occur as
early as the first year of life.1,2
Discriminating between primary and secondary glau-
coma can be particularly challenging in childhood because
of their occasional phenotypic overlap, the lack of certain
abnormalities at birth, and the difficulty of a thorough eye
examination in infants and young children.3,4 For example,
although heterozygous variants in FOXC15 or PITX26
account for 40% to 60% of ARS, FOXC1 variants may
also be associated with childhood glaucoma with only
mild features of ASD.4 This diagnostic challenge is
further highlighted by the occasional misdiagnosis of other
congenital conditions as childhood glaucoma, including X-
linked megalocornea or congenital hereditary endothelial
dystrophy.7
Recently, a unique form of autosomal recessive ASD was
associated with variants in CPAMD8 (ASD 8, Online
Mendelian Inheritance in Man 617319).8 Unlike other ASD
cases, none of the 4 original cases with biallelic CPAMD8
variants had glaucoma; only a single case was reported to
have developed ocular hypertension at 49 years of age,
suspected to have been exacerbated by ectopia lentis and
retinal surgery.8 Subsequently, congenital glaucoma
associated with lens subluxation was reported in a single
case with a homozygous frameshift variant in CPAMD8,
although no other clinical details were provided.3 A
homozygous variant in CPAMD8 has also been associated
with Morgagnian cataract in Red Holstein Friesian cattle,
with glaucoma observed in 1 of 8 eyes examined and
associated with uveitis and retinitis in the same eye.9
We investigated CPAMD8 variation in a cohort of pa-
tients with childhood glaucoma or juvenile open-angle
glaucoma diagnosed between 18 and 40 years of age.
Compound heterozygous or homozygous CPAMD8 variants
were identified in 11 affected individuals from 7 families,
each with a unique combination of anterior segment ab-
normalities and secondary glaucoma.Methods
Patient Recruitment
Patients and family members were recruited via the Australian &
New Zealand Registry of Advanced Glaucoma10 and provided
written informed consent under protocols approved by the
Southern Adelaide Clinical Human Research Ethics Committee.
The study was conducted in accordance with the revised
Declaration of Helsinki and followed the National Health and
Medical Research Council statement of ethical conduct in
research involving humans. Clinical diagnosis and details were
obtained from the treating ophthalmologist, and consent to
publish photographs was obtained from individuals or their legal
guardians. Parents and siblings of affected individuals were
recruited when available. Childhood glaucoma was defined as an
onset of glaucoma before 18 years of age as per The Childhood
Glaucoma Research Network classification system: in this cohort,
cases had been referred with a suspected diagnosis of primary
congenital glaucoma, which in some patients was later revised.112The juvenile open-angle glaucoma cohort consisted of in-
dividuals diagnosed between 18 and 40 years of age. All childhood
and juvenile open-angle glaucoma cases were screened for biallelic
CYP1B1 variants by capillary sequencing, with all juvenile open-
angle glaucoma cases also screened for heterozygous MYOC var-
iants. Each cohort included both advanced and nonadvanced
glaucoma cases.
DNA Sequencing and Analysis
DNA was prepared from whole blood or saliva samples. Genomes
were sequenced on the Illumina Hiseq X platform as previously
described.12 Exome capture was performed using the Agilent
SureSelect system (v4 or v5) and sequenced on an Illumina
HiSeq (2000 or 2500).13 Raw reads were aligned to the hg19
reference using BWA-MEM (v0.7.12) and sorted and duplicate-
marked with Picard (v1.13). Local indel realignment and base
quality score recalibration were performed using GATK (v3.4.0).
Variants were recalibrated using GATK Variant Quality Score
Recalibrator. The VCF files were annotated with ANNOVAR
using RefSeq, gnomAD (r2.0.2), 1000 Genomes (Phase 3),
NHLBI-ESP project (v2), ClinVar (20170905), and dbNSFP
(v3.3a) databases. The Combined Annotation Dependent Depletion
(CADD), Sorting Intolerant From Tolerant, and PolyPhen-2
HumVar tools were used to predict the effect of coding sequence
variants on protein function. Protein sequences were aligned with
Clustal Omega and BOXSHADE.
For initial variant filtering, we considered the subset of
nonsense, essential splice, missense, or frameshift PASS variants
with a gnomAD allele frequency < 0.001, genotype quality score
of > 20, and allele balance of > 0.25. With the exception of
essential splice variants, noncoding variants were not considered.
All 7 probands with biallelic variants in CPAMD8 had no rare
variants (at an allele frequency threshold of 0.0001) in CYP1B1,
MYOC, FOXC1, or PITX2. Variants identified through genome and
exome sequencing were confirmed in a National Association of
Testing Authoritieseaccredited laboratory (SA Pathology, Flinders
Medical Centre, Adelaide, Australia) using bidirectional capillary
sequencing of the relevant polymerase chain reactioneamplified
CPAMD8 region. Primer sequences are available upon request.
Polymerase chain reaction products were sequenced, and base
called on the Applied Biosystems 3130xl Genetic Analyzer
(Thermo Fisher Scientific, Waltham, MA). Detection of sequence
variants was performed with the aid of Mutation Surveyor v4.0
(SoftGenetics LLC, State College, PA), with trace files assembled
against the CPAMD8 (NM_015692.2) hg19 reference. Variants
have been submitted to ClinVar (https://www.ncbi.nlm.nih.gov/
clinvar/).
Clinical Single Nucleotide Polymorphism Array
A masked array of CPAMD8 copy number variation (GRCh37
assembly, 19:17003758-17137625) was performed using the Illu-
mina Infinium CytoSNP-850k Beadchip. Copy number variants
were called if 10 or more consecutive single nucleotide poly-
morphisms were suggestive of copy number gain or loss, giving an
average effective resolution of <0.1 Mb.
Tissue Dissection and RNA Preparation
Cadaveric human eyes with no known ocular disease and otherwise
unsuitable for corneal transplantation were obtained from the Eye
Bank of South Australia. Tissue dissection was performed under
light microscope with a mean postmortem time of 9.75.3 hours.
Tissues from the corneal epithelium, corneal stroma, corneal
endothelium, trabecular meshwork, pars plicata of the ciliary body,
retina, optic nerve head, and optic nerve were collected and fixed in
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at 80C. A standard Trizol extraction protocol was used for RNA
isolation. RNA extracted from the pars plicata was passed through
a Genomic-tip 20/G (Qiagen, Hilden, Germany) as per the manu-
facturer’s instructions to remove excess melanin. RNA quality was
assessed using the Agilent (Santa Clara, CA) Bioanalyzer 2100
RNA 6000 Nano Assay (mean RIN ¼ 6.51.8). A Qubit 2.0
Fluorometer (Thermo Fisher Scientific) was used to quantify RNA.
RNA Sequencing and Analysis
RNA libraries were prepared using the Bioo Scientific (Austin, TX)
NEXTflex Rapid Directional RNA-Seq Kit Bundle with RNA-Seq
Barcodes and poly(A) beads (NOVA-5138-10). Total RNA from
each tissue sample (250 ng) was prepared for individual
sequencing. Sequencing was performed on an Illumina NextSeq
500 using High Output v2 Kit (75 cycles) after sample enrichment
with 16 cycles of polymerase chain reaction. Phi X DNA was
spiked into each run pool. Trimgalore v0.4.0 was used to trim
sequence adaptors and low-quality bases (Phred scores < 28).
Remaining reads were aligned to the human genome (GRCh38
assembly) using TopHat v2.1.1, allowing for 2 mismatches per
read and no ambiguous reads. Uniquely aligned reads were an-
notated using the union model in HTSeq-count v0.6.0 with
Ensembl version 84 human gene ID. Trimmed mean of M-values
was used to normalize count data, followed by calculation of dif-
ferential expression in EdgeR v3.10.2. BenjaminieHochberg
adjustment was applied for false discovery rate correction.
Results
To investigate an underlying genetic architecture of child-
hood glaucoma, we recruited a cohort of 129 probands with
a diagnosis of childhood glaucoma. All 129 probands were
prescreened for biallelic variants in CYP1B1, which
accounted for 21 cases (16.3%). For the remaining 108
probands, we sequenced and analyzed 87 exomes and 1
genome for variants in CPAMD8. We identified rare (gno-
mAD allele frequency < 0.001) compound heterozygous
missense, nonsense, and frameshift variants in 7 individuals
from 5 unrelated families (Fig 1AeD), consistent with
suspected autosomal recessive inheritance in all families.
In a cohort of 206 ancestrally matched controls without
glaucoma, only 1 individual carried more than 1 rare
CPAMD8 coding variant (both missense, phase unknown),
with neither variant predicted to be damaging (Phred-
scaled CADD score of < 6). In family 1, the affected
proband (II:1), but not his unaffected sister (II:2), was a
compound heterozygote for variants inherited from either
parent. In family 2, the proband (II:1) was conceived via
sperm donation, with the unaffected mother and
unaffected father each confirmed to carry separate
heterozygous variants. In family 3, 2 affected sisters (II:1
and II:3), but not a third unaffected sister (II:2), carried
the same pair of compound heterozygous variants, with 1
variant carried by each unaffected parent (Fig 1A).
Two probands (families 4 and 5) were heterozygous for
the previously described c.2352dupC frameshift insertion
variant of CPAMD8 (p.(Arg785GlnfsTer23)).8 Both
probands had ocular features consistent with CPAMD8-
associated ASD (Fig 2), including iris stromal hypoplasia,
phacodonesis, iridodonesis, ectropion uveae, elevatedintraocular pressure (IOP), and glaucoma, yet neither
proband had a nonsense, essential splice, frameshift, or
missense variant on the second CPAMD8 allele to explain
the expected autosomal recessive inheritance pattern. To
broaden our search for a second disease-associated
CPAMD8 variant in these families, we evaluated larger
copy-number variants that are more readily detected by
genome sequencing or single nucleotide polymorphism
array than by capture-based short-read exome sequencing.
By using single nucleotide polymorphism array analysis, we
identified a maternally inherited 16 Kb heterozygous
duplication (chr19:g.17099980_17116595) in family 4,
spanning exons 8 to 13 of CPAMD8. Genome sequencing
was performed to characterize the nature of the duplication,
which revealed a direct tandem duplication of exons 8 to 13
of CPAMD8 (Fig 1C). This was predicted to introduce a
frameshift downstream of exon 8, with subsequent
nonsense-mediated decay of CPAMD8 transcript (Fig 1D).
Given the absence of larger copy number variants in
family 5, we expanded our search to in-frame insertion or
deletion variants. This revealed a multinucleotide variant
comprising a 3 nucleotide in-frame insertion
(c.3231_3232insGGA, p.(Leu1077_Ser1078insGly)), along
with an adjacent synonymous single nucleotide variant.
Together, these variants created a 4-nucleotide duplication
of an upstream sequence (TCCC), forming part of a larger 8
nucleotide tandem repeat (TCCCAGGATCCCAGGA).
Although this multinucleotide variant did not alter the
CPAMD8 reading frame, it did introduce an additional
glycine amino acid into the highly conserved farnesyl o-
methyltransferase domain (Fig 1). Because both parents
were deceased, we were unable to resolve the phase of
each CPAMD8 variant.
To test the possibility that CPAMD8 variation contributes
to glaucoma later in life, we also investigated a cohort of
139 probands diagnosed with juvenile open-angle glaucoma
between 18 and 40 years of age. All cases were screened for
variants in MYOC and CYP1B1, which accounted for 5
(3.6%) and 2 (1.4%) cases, respectively. Of the remaining
132 probands, we sequenced 96 exomes, which revealed an
additional 2 probands with biallelic CPAMD8 variants.
After screening relatives, a total of 4 individuals with ho-
mozygous loss-of-function CPAMD8 variants were identi-
fied within 2 consanguineous families (families 6 and 7)
(Fig 1A). Two of these individuals were diagnosed with
juvenile open-angle glaucoma, and 1 was receiving treat-
ment for ocular hypertension. Two cases (family 7, II:1 and
II:2) had a clinical diagnosis of Stickler syndrome, although
we found no evidence of rare and predicted pathogenic
variants in any of the Stickler-associated genes (COL2A1,
COL9A1, COL9A2, COL9A3, COL11A1, COL11A2).
All 10 CPAMD8 variants identified were rare or absent in
gnomAD at a frequency consistent with a rare recessive
disease (Table 1), with no observed homozygotes. Families
2 and 3 were not known to be related but both are of
Scottish ancestry and shared a single variant
(p.(Thr1433Asn)) found only in the non-Finnish European
cohort of gnomAD (5/125954 alleles). All identified
CPAMD8 missense variants were predicted to be damaging
by the CADD, PolyPhen-2, or Sorting Intolerant From3
Figure 1. Childhood glaucomawith anterior segment dysgenesis (ASD) in individuals with biallelicCPAMD8 variants.A, Pedigrees of the 7 families described
in this study. In family 2, the proband was conceived via a sperm donor.Round symbols indicate female patients; square symbols indicate male patients; black
symbols indicate childhood glaucoma; arrow indicates proband. D¼ sperm donor;þ¼ reference allele. B,CPAMD8 locus and location of disease-associated
variants described in this study and others.3,8,9 C, Direct tandem duplication encompassing CPAMD8 exons 8e13, as identified by short-read genome
sequencing. D, CPAMD8 protein schematic and domain structure showing the location of disease-associated missense, nonsense, and frameshift variants
(location of relevant splice junctions and splice variants are indicated with dashed lines). A2M¼ a2-macroglobulin domain; TE¼ thioester site. E,CPAMD8
protein sequence alignments across multiple vertebrate species. Residues of interest are highlighted for variants p.(Leu489Pro), p.(Cys500Arg), p.(Pro1188-
Leu), and p.(Thr1433Asn). F, CPAMD8 expression in adult human donor ocular tissue. RPKM ¼ reads per kilobase per million mapped reads.
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Figure 2. ASD phenotypes in individuals with biallelic CPAMD8 variants. AeD, Clinical photographs of the right eye (RE, left panels) and the left eye
(LE, right panels) of the specified individuals. Family 1 (A): superior corectopia, initially suspected to be secondary to trabeculotomy surgery (A, RE) and iris
stromal hypoplasia (A, both eyes). Family 2 (B, RE): subtle superonasal corectopia and mild iris stromal hypoplasia. Family 3 (C): superonasal corectopia
(II:1, both eyes; II:3, LE), iris stromal hypoplasia (II:3, both eyes). Family 5 (D): bilateral superior iridectomies (II:1); inferior iris coloboma, dense nuclear
cataract, ectropion uveae (II:3, RE); partial inferior iris coloboma, ectropion uveae (II:3, LE). Family 6 (F): bilateral iridectomies, ectropion uveae
(magnified view of RE), iris transillumination (RE). Family 7 (E): broad peripheral iridectomy, band keratopathy, iris stromal hypoplasia. Temporal pe-
ripheral corneal opacities in family 1 (II:1, bilateral), family 3 (II:3, RE), and family 7 (II:1, RE) were a suspected consequence of surgery.
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Table 2. Clinical Summary of Individuals with Biallelic CPAMD8
Variants
Variable Value
Female (%) 5/11 (45.5)
Best-corrected visual acuity (decimal) 0.420.32
Preoperative refraction (D) 8.569.37
Cataract (%) 8/11 (72.7)
Age at cataract diagnosis or surgery (yrs) 35.7512.28
Phacodonesis (%) 5/11 (45.5)
Ectopia lentis (%) 4/11 (36.4)
Iris stromal hypoplasia (%) 6/11 (54.5)
Ectropion uveae (%) 5/11 (45.4)
Iridodonesis (%) 5/11 (45.5)
Iris transillumination (%) 4/11 (36.4)
Corectopia (%) 3/11 (27.3)
Posterior embryotoxon (%) 1/11 (9.1)
Retinal detachment (%) 3/11 (27.3)
Age at first retinal detachment (yrs) 309.17
Glaucoma (%) 9/11 (81.8)
Age at glaucoma diagnosis (yrs) 9.2214.89
Buphthalmos (%) 5/11 (45.5)
Haab striae (%) 2/11 (18.2)
Max IOP (mmHg) 3610
Highest corneal diameter (mm) 14.31.7
Mean CCT (mm) 60992
Worst VCDR 0.620.23
Worst mean deviation (dB) 8.929.90
CCT ¼ central corneal thickness; D ¼ diopter; IOP ¼ intraocular pressure;
VCDR ¼ vertical cup:disc ratio. Continuous variables are expressed as
mean  standard deviation and categoric variables as percentages.
Table 1. CPAMD8 Variants Associated with Anterior Segment Dysgenesis and Glaucoma
Family gDNA cDNA Exon Protein gnomAD AC (AF) CADD PP2 SIFT
1 chr19:g.17038927G>A c.3403C>T 25 p.(Arg1135Ter) 10/276872 (0.00003612) 38
chr19:g.17036131G>A c.3563C>T 26 p.(Pro1188Leu) 4/246198 (0.00001625) 25.9 1; D 0.031; D
2 chr19:g.17015130G>T c.4298C>A 32 p.(Thr1433Asn) 5/276098 (0.00001811) 24.1 0.955; D 0.008; D
chr19:g.17100491A>G c.1498T>C 13 p.(Cys500Arg) 25.7 0.997; D 0.006; D
3 chr19:g.17015130G>T c.4298C>A 32 p.(Thr1433Asn) 5/276098 (0.00001811) 24.1 0.955; D 0.008; D
chr19:g.17100523A>G c.1466T>C 13 p.(Leu489Pro) 1/245962 (0.000004066) 24.7 0.963; D 0.211; T
4 chr19:g.17081702dupC c.2352dupC 18 p.(Arg785Glnfs*23)
chr19:g.17099980_17116595dup
5 chr19:g.17081702dupC c.2352dupC 18 p.(Arg785Glnfs*23)
chr19:g.17039805insGGA c.3231_3232insGGA 24 p.(Ser1078delinsGlySer)
6 chr19:g.17062979T>A c.2449A>T 20 p.(Lys817Ter) 35
7 chr19:g.17049229insG c.2961dupG 23 p.(Tyr988LeufsTer9) 1/215022 (0.000004651)
Position of each disease-associated variant with the human genome (hg19 reference), consensus transcript (NM_015692.5), and protein (NP_056507.3)
described using HGVS nomenclature (version 15.11). Allele counts and allele frequencies of each variant in the gnomAD database (v2.1.1) are shown, as
are Phred-scaled CADD (v1.4), PolyPhen-2 HVAR (PP2) and SIFT scores with predictions of deleteriousness. AC ¼ allele count; AF ¼ allele frequency;
CADD ¼ combined annotation dependent depletion; D ¼ damaging/deleterious; T ¼ tolerated.
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CPAMD8 protein sequences demonstrated strong
conservation at the position of each of the missense
variant residues (Fig 1E).
CPAMD8 is known to be expressed in the anterior
segment of the developing human eye, with high expression
in the developing human lens, iris, and cornea at 22 weeks’
gestation.8 We further assessed CPAMD8 expression in an
RNAseq dataset from ocular tissue of recently deceased
adult donors and identified highest expression in the
ciliary body and corneal epithelium with minimal
expression in retina (Fig 1F), consistent with the
expression pattern in the developing human eye.
Clinical data summarized across all 11 affected in-
dividuals revealed some key similarities to previously
described cases of CPAMD8-associated ASD (Fig 2,
Table 2, Table S1, available at www.aaojournal.org).8 The
majority of cases were noted to have 1 or more
abnormalities of the iris (9/11), with a subset displaying
stromal hypoplasia (6/11), iridodonesis (5/11), ectropion
uveae (5/11), or corectopia (4/11) (Fig 2). There was a
tendency toward high myopia, with a mean preoperative
spherical equivalent of 8.569.37 D, although at least 1
individual was a þ3.50 hyperope (family 3, II:3).
The majority of individuals (9/11, 81.8%) were diag-
nosed with glaucoma, all of whom (9/9) required incisional
surgery to control IOP and most of whom (8/9, 88.9%)
required multiple incisional procedures. The majority (6/11,
54.5%) of individuals were diagnosed with primary
congenital glaucoma at birth, 1 with childhood glaucoma at
15 years of age, 2 with juvenile-onset open-angle glaucoma
at 33 and 35 years of age, and 1 was receiving pharmaco-
logic treatment for bilateral ocular hypertension at 53 years
of age (family 6, II:2). Within our cohort, glaucoma pene-
trance was 54.5% (6/11) at 10 years of age and 63.6% (7/11)
at 25 years of age. Across all reported CPAMD8 cases, the
cumulative glaucoma risk was 43.8% by 10 years of age and
50.0% by 25 years of age (95% confidence interval, 0e68
years) (Fig 3A).6Cataracts were present in 8 of 11 individuals (72.7%).
The presence of buphthalmos in the proband of family
2 (II:1) made this cataract surgery challenging, and the
patient was left aphakic. Bilateral retinal detachment
occurred in 3/11 individuals. Across all reported CPAMD8
cases, the cumulative risk of cataract diagnosis or surgery
was 50% at 33 years of age (95% confidence interval,
Figure 3. Age-associated prevalence of glaucoma, cataracts, or retinal detachment in individuals with bialleleic CPAMD8 variants. Including the 11 cases
described here, plus 5 previously reported cases.3,8 A, Cumulative glaucoma risk, with a cumulative risk of 50% at 24 years of age (dotted line). B,
Cumulative cataract risk. Ages represent age at cataract diagnosis or age at cataract surgery (age at diagnosis used where both were known), with a
cumulative risk of 50% at 33 years of age (dotted line). C, Cumulative risk of retinal detachment in 1 or both eyes. Grey shading indicates 95%
confidence intervals.
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retinal detachment in 1 or both eyes approaching 50%.Discussion
We describe the largest cohort of individuals to date with
biallelic variants in the CPAMD8 gene and characterize its
associated ocular phenotype. We provide evidence that this
phenotype is broad, ranging from childhood and juvenile
open-angle glaucoma with ASD to early-onset cataract and
retinal detachments. Although consistently associated with
abnormalities of the iris or lens, individuals with biallelic
CPAMD8 variants did not necessarily meet the definition of
an existing disease entity. We note that in addition to ASD,
biallelic CPAMD8 variants can be associated with childhood
and juvenile open-angle glaucoma, even in the absence of
ectopia lentis. Within an Australian cohort of childhood
glaucoma probands explained by any genetic diagnosis,
biallelic CPAMD8 variants accounted for at least 3.9% of
individuals (5/129), second only to CYP1B1, which
accounted for 16.3% in the same cohort. This was equiva-
lent to the frequency associated with heterozygous loss-of-
function variants in TEK14 or FOXC1.4 In our cohort of
patients with juvenile-onset glaucoma diagnosed at 18 to
40 years of age, CPAMD8 variants accounted for at least
1.4% (2/139) of probands, second only to MYOC (5/139,
3.6%), and at a frequency equivalent to CYP1B1.
It was also apparent that in several cases the clinical
diagnosis was not clear initially, with several cases referred
to as primary congenital glaucoma, despite the presence of
anterior segment defects. This is not an uncommon occur-
rence in primary congenital glaucoma, for which diagnoses
are often revised after examinations under anesthesia, res-
olution of corneal opacity, or in some cases in which a
careful examination is prompted by a new molecular
diagnosis.4
Not all CPAMD8 variants were immediately apparent on
exome sequencing, despite the presence of a known disease-
associated frameshift variant and a strong phenotypic
resemblance to other CPAMD8-associated cases. We found
that in these cases, examination of copy number variants or
less stringent filtering of exome sequencing data could reveala second allele.12 This has important implications for
screening, where a heterozygous rare and predicted
deleterious CPAMD8 variant in a clinically compelling case
should invite further molecular scrutiny of the second allele.
Ascertainment bias makes it difficult to accurately esti-
mate glaucoma penetrance in CPAMD8-associated ASD.
Within the limits of available patient data (16 total
CPAMD8 cases, including the 11 described), we estimated
glaucoma penetrance in CPAMD8-related ASD to be 62.5%
(10/16), which is similar to more reliable estimates in ARS.1
Other causes of ASD, notably ARS caused by FOXC1 or
PITX2 variants, have a well-defined association with glau-
coma, with a glaucoma prevalence of 58.5% in a cohort of
53 cases.2 The penetrance at age 10 years among individuals
with CPAMD8 (43.8%) was similar to previous estimates in
individuals with FOXC1 variants (42.9%).2 Glaucoma is
often difficult to treat in ARS,1,15 and CPAMD8-
associated ASD appears to be no exception, with all
individuals in this report diagnosed with glaucoma
requiring incisional surgery to control IOP and
approximately 90% requiring multiple procedures. Family
1 (II:1) is a striking example; the proband, diagnosed with
glaucoma within the first 2 weeks of life, required 5
IOP-lowering interventions in each eye within the first 4
years of life.
The CPAMD8-related ASD phenotype was associated
with lens or iris anomalies in all affected individuals.
Commonly associated ocular features included iris stromal
hypoplasia (6/11), iris transillumination defects (4/11),
corectopia (4/11), ectropion uveae (5/11), iridodonesis (5/
11), and ectopia lentis (4/11). Polycoria, often seen in ARS
associated with FOXC1 and PITX2 variation, was not re-
ported in any reported CPAMD8 cases, and posterior
embryotoxon was reported in only 1 individual. Cataracts
were present in 8 of 11 individuals. These phenotypes
suggest lens instability and pupillary block as 1 potential
underlying cause of CPAMD8-associated glaucoma,
consistent with its predominant expression in the adult
ciliary body. However, we observed glaucoma in at least 1
case diagnosed with buphthalmos at birth without lens
instability (family 1, II:1), implying aqueous outflow
dysfunction is also likely to be implicated. An array of
anterior segment abnormalities also highlights the7
Ophthalmology Volume -, Number -, Month 2020challenges a surgeon could expect to encounter: for
example, buphthalmos complicating cataract surgery and
intraocular lens placement in family 2 (II:1). A requirement
for multiple incisional procedures to control IOP (8/11), an
increased rate of zonular instability (5/11), and bilateral
retinal detachment (3/11) highlight further complexities in
managing such patients.
CPAMD8 (complement component 3- and pregnancy
zone protein-like alpha-2-macroglobulin domain-
containing protein 8) is 1 of 8 members of the comple-
ment 3/a2-macroglobulin (C3/a2M) family reported in
humans.16 Other C3/a2M family members include the
complement components C3, C4A, C4B, and C5; a2M;
pregnancy zone protein; and CD109. C3, C4A, C4B, C5,
and a2M proteins are all abundant in plasma, whereas
CD109 is a GPI-anchored cell-surface molecule, and
CPAMD8 is membrane associated. Although CPAMD8
was initially suspected to play a role in immunity, its
physiologic function is still not known.16 The conspicuous
absence of a CPAMD8 ortholog in rodent genomes makes
this gene challenging to study in model organisms,
although limited inference can be made from RNA
expression studies. CPAMD8 is consistently expressed in
tissues of neural crest origin,17 including the lens, iris,
and cornea in utero,8 and the ciliary body and corneal
epithelium in adult eyes. This pattern is consistent with
hypoplasia of the iris stroma in patients with CPAMD8
variants, whereas neuroectoderm-derived pigmented
epithelial cells develop normally. Other key drainage
structures in the eye, including the trabecular meshwork
and Schlemm’s canal, are also derived from neural crest
progenitors and may be hypoplastic or otherwise
dysfunctional in the absence of CPAMD8. But unlike
other ASDs defined by neural crest dysfunction,18
CPAMD8 deficiency does not appear to cause other
neural cresteassociated malformations involving dental,
craniofacial, and aortic structures. With respect to the
mechanism of high-pressure glaucoma, both outflow
obstruction (through dysplasia or dysfunction of outflow
structures) and lens instability (through ciliary zonule
dysfunction) could be consistent with the observed
CPAMD8 expression patterns, although our analyses do
not capture the full temporal and spatial variation of
CPAMD8 expression. In any case, the observation of 4
affected individuals with biallelic nonsense or frameshift
variants suggests that loss of CPAMD8 function is
responsible.
In conclusion, our findings reveal that biallelic CPAMD8
variants are associated with a clinically heterogeneous
phenotype, including frequent associations with autosomal
recessive childhood glaucoma (3.9%) and juvenile open-
angle glaucoma (1.4%). CPAMD8 should be considered in
the differential diagnosis of both childhood and juvenile
open-angle glaucoma, particularly when associated with iris
abnormalities, cataract, or retinal detachment. This pheno-
typic characterization has important implications for
improved clinical care, including providing appropriate ge-
netic testing and counseling, and more accurate prognosti-
cation of expected complications.8References
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